与克洛扎宾相关的死亡率:有什么证据?
Emilio Fernandez-Egea1, Robert J Flanagan2, David Taylor3
1Cambridge Psychosis Centre, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; and Department of Psychiatry, University of Cambridge, Cambridge, UK.
概括
尽管存在风险,但克洛扎宾的使用可能会降低精神分裂症患者的整体死亡率,特别是通过降低自杀率. 建议改善监测和更早,更广泛的使用,以防止死亡.
科学领域:
- 药物监督和药物安全研究.
- 抗精神病药物的临床药理学.
背景情况:
- 克洛扎是一种非典型的抗精神病药物,用于治疗耐药精神分裂症.
- 有关克洛沙的安全性和相关的死亡风险存在担忧.
研究的目的:
- 批判性地评估与克洛扎使用相关的死亡风险.
- 评估英国药物监督计划对克洛扎的有效性.
- 确定克洛扎宾对精神分裂症患者死亡率的整体影响.
主要方法:
- 对克洛扎的英国药监数据的分析.
- 与其他抗精神病药物相比,克洛沙的风险概况.
- 用克洛扎宾治疗的患者死亡率数据的评估.
主要成果:
- 与克洛沙平相关的相对死亡风险似乎被高估了.
- 英国的克洛扎药物监测系统是有效的,尽管由于报告变化,药物之间的比较可能会产生误导性.
- 克洛扎的使用与整体死亡率的降低有关,主要是由于精神分裂症患者的自杀率下降.
- 尽管有好处,但与克洛扎治疗相关的可预防死亡仍在发生.
结论:
- 克洛扎在精神分裂症中提供了死亡率的好处,主要是通过减少自杀.
- 需要更早,更广泛地使用克洛札.
- 加强对克洛扎毒性的监测和改进的管理策略对于最大限度地提高患者安全和治疗效益至关重要.
相关概念视频
Biological Causes of Schizophrenia
47
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
47
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Schizophrenia
72
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
72
Comparing the Survival Analysis of Two or More Groups
156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
507
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
507
Antidepressant Drugs: MAOIs and Other Agents
200
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
200


